Emerging research suggest this peptide, a dual activator targeting both GLP-1 and glucose-dependent insulinotropic polypeptide , appears to represent a significant step forward for weight treatment. https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide